Phase II trial of intravesical gemcitabine in bacille Calmette- Guérin-refractory transitional cell carcinoma of the bladder Academic Article uri icon

Overview

MeSH Major

  • Antimetabolites, Antineoplastic
  • Carcinoma, Transitional Cell
  • Deoxycytidine
  • Urinary Bladder Neoplasms

abstract

  • Gemcitabine has activity in a high-risk patient population and remains a viable option for some patients who refuse cystectomy.

publication date

  • June 20, 2006

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2005.05.2720

PubMed ID

  • 16782913

Additional Document Info

start page

  • 2729

end page

  • 34

volume

  • 24

number

  • 18